The presence of Pars Isotope at the 18th International Congress of Breast Cancer

The 18th International Breast Cancer Congress, sponsored by Pars Isotope, was held on 8-10 January. This conference was organized by the Cancer Research Center at Shahid Rajaei Hospital Heart Hotel. On its side, there was an exhibition, one of whose stands was dedicated to Pars Isotope.

During the exhibition days, Pars Isotope’s stand, which focused on its usual, new and future products in the field of breast cancer diagnosis and treatment, hosted breast cancer surgeons and oncologists who had questions about Pars Isotope’s diagnostic and therapeutic radiopharmaceuticals for breast cancer.

The radiopharmaceuticals Ga-68-FAPI-2286 and Lu-177-FAPI-2286, which are among the newest products of Pars Isotope in the field of breast cancer diagnosis and treatment, were presented at this congress and their applications were mentioned. These two products have the ability to detect all types of breast cancer metastases and treat them completely. One of the target groups of this congress was nuclear medicine, and nuclear doctors introduced this product to surgeons and oncologists by attending this congress.

Pars Isotope, as the only manufacturer and supplier of diagnostic and therapeutic radiopharmaceuticals in Iran, always adheres to its mission of promoting public health, especially in the field of cancer diagnosis and treatment.